![Gavin Malenfant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gavin Malenfant
Nessuna posizione attualmente
Profilo
Gavin T.
Malenfant is the founder of GMalenfant Consulting LLC, founded in 2018.
Former positions include Head-Operations & Vice President at Sarepta Therapeutics, Inc. from 2015 to 2016, Head-Operations at Genzyme Corp., Head-Corporate Operations & Program Management at Akebia Therapeutics, Inc. from 2016 to 2018, and Chief Operating Officer at ProMIS Neurosciences, Inc. from 2021 to 2025.
Education includes an undergraduate degree from the University of Massachusetts Boston.
Precedenti posizioni note di Gavin Malenfant
| Società | Posizione | Fine |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Direttore operativo | 14/02/2025 |
GMalenfant Consulting LLC | Fondatore | 01/10/2021 |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2018 |
| SAREPTA THERAPEUTICS, INC. | Direttore operativo | 01/01/2016 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Direttore operativo | - |
Formazione di Gavin Malenfant
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
University of Massachusetts Boston
 University of Massachusetts Boston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GMalenfant Consulting LLC |
